GKB.BO
Get informed when a big investor buys or sells
+ Follow| Market cap | $306.67 Million |
|---|---|
| Enterprise Value | $374.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.42 |
| Beta | 0.46 |
| Outstanding Shares | 5,040,580 |
| P/E Ratio | 9.46 |
|---|---|
| PEG | -4.76 |
| Price to Sales | 0.2 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | 5.66 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
GKB Ophthalmics Ltd. operates as a holding company, primarily engaged in the production and distribution of ophthalmic lenses crafted from both glass and plastic. The firm's comprehensive product portfolio encompasses mineral, finished, ...